{"database": "openregs", "table": "documents", "rows": [["FDA-2023-D-1909-0001", "FDA", "FDA-2023-D-1909", "Enhanced Drug Distribution Security Requirements Under Section 582(g)(1)\nof the Federal Food, Drug, and Cosmetic Act\u2014Compliance Policies; Guidance for Industry; Availability", "Rule", "Advance Notice of Proposed Rulemaking (ANPRM)", "2023-08-28T04:00:00Z", 2023, 8, null, null, "2023-08-28T14:19:12Z", "2023-18359", 0, 0, "0900006485f00191"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-D-1909-0001"], "units": {}, "query_ms": 0.3553749993443489, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}